MTOR and neoplasm: In addition to the tumors collected in the long-term (LT) study in Fig. 3A, we also collected tumors from a separate short-term (ST) study, after 30 d of treatment with the vehicle and after 38 d of treatment with everolimus, when tumor growth was still suppressed by the mTOR inhibitor (SI Appendix, Fig. S4A).